You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: Institute of Cancer Research » Outputs » Detail

Output details

1 - Clinical Medicine

Institute of Cancer Research

Return to search Previous output Next output

Output 277 of 298 in the submission

Article title

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

Type

D - Journal article

DOI

10.1158/1078-0432.CCR-09-2483

Title of journal

Clin Cancer Res

Article number

Volume number

Issue number

First page of article

1613

ISSN of journal

1078-0432

Year of publication

2010

URL

http://www.ncbi.nlm.nih.gov/pubmed/20179232

Number of additional authors

Additional information

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract